As abelhas da tribo Meliponini apresentam ampla distribuição, ocupando principalmente as regiões neotropicais do planeta. São encontradas mais de 400 espécies pertencentes a 50 gêneros. Tetragonisca angustula é uma espécie que se distribui por praticamente toda a América Latina, sendo em geral bastante abundante.No presente projeto foram empregadas técnicas moleculares (sequenciamento de DNA mitocondrial e análise de loci de microssatélites) no intuito de se verificar a variabilidade em duas pequenas populações de Tetragonisca angustula distribuídas nos campi da USP de Ribeirão Preto e São Paulo. Para a obtenção de um panorama da variabilidade da espécie, foram coletados e analisados indivíduos de áreas externas aos campi. Os resultados de sequenciamento mostraram que a variabilidade do genoma mitocondrial das amostras externas é muito maior que a variabilidade nas amostras dos campi. Além disso, ficou claro que os campi contêm populações monofiléticas bastante isoladas entre si, e que cada uma possui maior similaridade com as amostras externas do que com as amostras do outro campus. Em contrapartida, os resultados de microssatélites mostraram que a variabilidade dessas populações para os loci estudados é extremamente similar. Isso sugere que a filopatria da espécie é muito grande, e que o vôo dos machos é responsável por, de certa forma, homogeneizar a variabilidade genética das populações, impedindo que haja muita estruturação. Dessa maneira, em uma população de T. angustula, existem dois números efetivos populacionais: um para as fêmeas (estimado pela variabilidade do DNA mitocondrial) e outro maior para machos (estimado pela variabilidade dos microssatélites). Os resultados indicam que a colonização dos campi se deu por um número pequeno de rainhas que posteriormente aumentaram a população por conta da grande quantidade de recursos que os campi possuem / The bees of the Meliponini tribe have a broad distribution, mainly throughout the neotropical regions of the planet. There are over 400 species distributed among 50 genera. Tetragonisca angustula is a species which occupies almost all Latin America, generally in large individual numbers. In this study we used molecular techniques (mitochondrial DNA sequencing and analysis of microsatellite loci) to obtain measures of the genetic variability in two small populations of T. angustula located in both the campi of USP, Ribeirão Preto and São Paulo. In order to get a better idea of the variability of the species as a whole, we also analyzed individuals from populations from outside the campi. The results of the DNA sequencing showed that the variability of these external samples is far bigger than the variability of the other two populations. Also, it became clear that both campi have monophyletic populations that are very isolated from each other, and that each one of these campus populations is phylogenetically closer to the external samples than they are to each other. On the other hand, the results obtained with microsatellites showed that the variability of the populations from both campi are very similar to the variability of the external samples. This suggests that there is a high degree of filopatry in the species, and that the male flight is responsible, in a way, for mixing the genetic variability of the populations, this way keeping them from getting structured. Thus, in a given population of T. angustula, there are two different effective population sizes: of for the females (measured by the variability in the mitochondrial DNA) and another for the males (measured by the variability in the microsatellites). Our results indicate that the process of colonization in both campi was carried out by a few queens, which lately were responsible for increasing the population sizes due to the big amount of resources found in the campi

L’augmentation constante de l’obésité dans les populations occidentales accroit la prévalence de nombreuses maladies liées au surpoids parmi lesquelles le syndrome d’apnées hypopnées du sommeil (SAHOS). Le SAHOS et l’obésité représentent deux facteurs de risque indépendants du développement de maladie cardiovasculaires (CV) et métaboliques. Etant souvent associés en pratique clinique, l’étude de leurs effets vasculaires et métaboliques spécifiques est difficile. Pour nous affranchir de cette problématique, nous avons étudié chez la souris, les effets respectifs et combinés d'un régime riche en graisse et/ou de 15 jours d'exposition à des conditions d'hypoxie intermittente (HI) mimant le SAHOS, sur les paramètres vasculaires et métaboliques. L’HI seule n'avait aucun impact sur le bilan-glucido lipidique, la fonction mitochondriale hépatique et la fonction vasculaire des animaux. Les animaux soumis au RRG présentaient une dyslipidémie,une stéatose hépatique, une dysfonction mitochondriale ainsi qu'une une dysfonction endothéliale. Lorsque l’HI était appliquée aux animaux recevant le RRG, l’ensemble de ces dysfonctions vasculaires, hépatiques et mitochondriales était prévenu mais une hyperinslinémie marquée était notée. Ce travail illustre les effets polymorphes de l’HI qui, pour des durées d’exposition courtes, pourrait présenter des effets bénéfiques sur les altérations associées à l’obésité qui contrastent avec les effets délétères à plus long terme décrits dans le SAHOS. / Decades increases the prevalence of many overweigh tassociated diseases including obstructive sleep apnea (OSA). Both OSA and obesity are considered as independent cardio-vascular and metabolic risk factors.The frequent association of OSA and obesity in clinical setting makes difficult to investigate their independent contribution to metabolic and vascular diseases. In the present thesis, we aimed to evaluate the impact of a short term intermittent hypoxia (IH), (animal model of OSA), of a high fat diet (HFD), and of both experimental conditions together (IH and HFD) on the vascular and metabolic outcomes. Short term IH alone had no impact on glucose and lipids levels and mitochondrial and vascular function. Animals fed with HFD presented dyslipidemia, hepatic steatosis, mitochondrial and endothelial dysfunction. Interestingly, when short term IH was applied to HFD fed mice, insulin level was increased, restored endothelial function and mitochondrial activity was restored and limited liver lipid accumulation was limited.Those data underline the polymorphic effects of IH that might target beneficial outcomes when applied for a short term in obesity, which contrast with the deleterious long term outcomes observed in OSA.

Leber’s hereditary optic neuropathy (LHON) is the most commonly inherited disease that causes blindness in one or both eyes, with a minimum prevalence of 1 in 31 000 in the northeast of England. What causes LHON is not fully known but three mitochondrial mutations, G3460A, G11778A, and T14484C, have been identified in over 95 % of all LHON patients. To diagnose LHON, detection methods like sequencing, allele specific polymerase chain reaction and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) are used to identify these three mutations. The methods are now evolving into multiplex ones to increase efficiency, the aim of this study was therefore to optimize one of them, a multiplex PCR-RFLP method developed in 2015. This study was however not completed, due to the COVID-19 pandemic, but a series of preparatory steps were performed before its termination. DNA extraction was performed, both genomic and plasmid, using a kit and in-house protocols. The DNA was then used for polymerase chain reactions (PCRs), for both the human β-globin gene and for the three mutations, where magnesium concentration and annealing temperature was optimized. This study resulted in clear, high quality extractions, with the kit as the preferable method. It also indicated that a 3 mM magnesium concentration and an annealing temperature of 59 °C was optimal for all mutations when using so called LHON primers. The conditions for the PCR using the multiplex primers might be different, therefore a new study is required to evaluate the multiplex PCR-RFLP method further. / Bakgrund: Lebers hereditära optikusneuropati (LHON) är en vanlig ärftlig sjukdom som orsakar blindhet. LHON orsakas i över 95 % av fallen av en av tre mitokondriella mutationer, där en byggsten i mitokondriens DNA felaktigt bytts ut mot en annan. Dessa mutationer heter G3460A, G11778A och T14484C. För att diagnostisera sjukdomen detekteras mutationerna, bland annat genom att extrahera DNA från blod, DNA som man sedan skapar otaliga kopior av genom en metod som heter ”polymerase chain reaction” (PCR). Dessa kopior kan sedan klyvas i bitar med hjälp av enzym och baserat på fragmentens storlek kan det avgöras om personen har mutationen eller inte, detta kallas för ”restriction fragment length polymorphism” (RFLP). I nuläget letar man efter en mutation i taget men det har utvecklats några metoder där man kan hitta alla mutationer på en gång och den här studiens syfte var att undersöka hur man på bästa sätt kan utföra en av dessa metoder, en så kallad multiplex PCR-RFLP. Metod: Studien avbröts i förtid på grund av ett pandemiskt utbrott av COVID-19 men hann omfatta DNA-extraktion från humant blod och bakterier med hjälp av ett kommersiellt kit och laboratoriets egna protokoll. Även PCR utfördes för en normal genuppsättning och de tre mutationerna. Resultat och slutsats: Extraktionen gav bra resultat med alla metoder men det kommersiella kitet gav bäst resultat. PCR med det DNA som extraherats fungerade bara ibland vilket gjorde det svårt att dra några större slutsatser, oavsett krävs fler studier för att undersöka metoden eftersom arbetet inte kunde slutföras.

Neurodegenerative diseases are highly multifaceted. Despite their heavy burden, treatment options are limited and our understanding of their molecular triggers even less so. In this thesis, I focus on the pathogenesis of Alzheimer’s Disease (AD) due to familial, sporadic and environmental causes. Previous research shows that early AD stages are characterized by upregulated functionality of mitochondria-associated endoplasmic reticulum (ER) membranes. These “MAM” domains of the ER are dynamic contacts between the ER and mitochondria distinguished by a unique lipid composition equivalent to a lipid raft. These sites cluster a specific set of metabolic enzymes that regulate cellular lipid uptake, trafficking and turnover. We find that cleavage of the amyloid precursor protein at MAM domains is intimately involved in MAM regulation through localization of its C-terminal fragment of 99 a.a., C99, to MAM regions. C99 upregulates MAM functionality by promoting cholesterol uptake and trafficking to the ER for esterification, observable in both familial and sporadic AD samples. Here, we recapitulated these phenotypes in a mouse model of an environmental AD trigger: traumatic brain injury (TBI). Through biochemical, transcriptional and lipidomic analyses, we observed MAM functionality to be upregulated following a single brain injury. This was determined by assessment of phospholipid synthesis and cholesterol esterification. This correlated with increased deposition of C99 in MAM domains as well as cell type-specific lipidomic alterations. Specifically, cholesterol esterification was predominant in microglia, triglyceride elevations were predominant in microglia and astrocytes, and polyunsaturated phospholipid elevations were predominant in neurons. We hypothesize that, in the acute phase, MAM upregulation serves to promote lipid synthesis for tissue repair. However, if these phenotypes are sustained (such as after multiple injuries), cognitive functions dependent on neuronal functionality could become compromised. Altogether, we propose that the induction of AD pathogenesis following brain injury may arise from chronic upregulation of MAM activities. This work advances our understanding of neurodegenerative disease etiology.

Trypanosoma brucei is the causative agent of Human African Trypanosomiasis (HAT), also known as African sleeping sickness. T. brucei is unique in several ways that distinguish this organism from other eukaryotes. One of the unique features of T. brucei is the organism’s mitochondrial DNA, which is organized in a complex structure called kinetoplast DNA (kDNA). Since kDNA is unique to the kinetoplastids, kDNA may serve as a good drug target against T. brucei. Previews studies have shown that kDNA has 4 different family A mitochondrial DNA polymerases. Three of these mitochondrial DNA polymerases (POLIB, POLIC, and POLID) are essential components of kDNA synthesis and replication. POLID and POLIC dynamically localize throughout the cell cycle. POLID is found dispersed in the matrix before the kDNA has undergone replication and is re-localized at the antipodal sites when the kDNA is dividing. POLIC is found in the kinetoflagellar zone (KFZ) at low concentrations when the kDNA is not replicating and relocalizes to the antipodal sites when dividing. Based on the dynamic localization of these two DNA polymerases, we hypothesize that POLIB undergoes dynamic localization at some point during the cell cycle stage. Here, a POLIB/PTP single expressor cell line was analyzed by immunofluorescence microscopy in an unsynchronized population. We characterized the localization pattern of POLIB-PTP at different cell cycle stages and found different localization patterns throughout cell cycle. Cells at 1N1K (the majority of cell in an unsynchronized population) have single foci, but at 1N1Kdiv two different patterns are mainly observed, diffuse and segregated. When the kDNAs are separated POLIB-PTP is again seen as a distinct foci in each kDNA. By doing TdT labeling and a quantitative analysis, we found that at early stages of minicircles replication POLIB-PTP start relocalizing to the kDNA disk with a diffuse pattern being the main. By the time the minicircles are being reattached in the disk (late TdT), POLIB is seen in the disk as a bilobe shape.

京都大学 / 新制・課程博士 / 博士(理学) / 甲第23034号 / 理博第4711号 / 新制||理||1675(附属図書館) / 京都大学大学院理学研究科化学専攻 / (主査)教授 杉山 弘, 教授 深井 周也, 教授 秋山 芳展 / 学位規則第4条第1項該当 / Doctor of Science / Kyoto University / DGAM

No description available.

Tumourigenic cells utilize aberrant metabolic process that supports the biosynthetic requirements for hyperproliferation, survival and prolonged maintenance characterised by glucose metabolism to lactate dehydrogenase independent of oxygen availability (Warburg effect). In addition, tumourigenic cells exert increased glycolytic- and glutaminolytic activity in order to provide increased quantities of adenosine triphosphate. The aim of this research project was to investigate the influence of glutamine deprivation on proliferation, morphology, oxidative stress, mitochondrial membrane potential, cell cycle progression, antioxidant defences, deoxyribonucleic acid (DNA) damage, energy status, cell survival signaling and cell death induction in tumourigenic- and non-tumourigenic breast cell lines. In this study it was found that glutamine deprivation results in differential antiproliferative activity where the MCF-7 cell line was the most affected with decreased cell growth to 61% after 96 h of glutamine deprivation. Aberrant redox activity was most prominently observed in the MCF-7 cell line accompanied with biphasic mitochondrial membrane potential- and reactive oxygen species production. The MCF-7 cell line showed significant mitochondrial membrane depolarisation after 24 h and 96 h deprivation from glutamine (1.5- and 1.37 fold). Cell cycle progression analysis illustrated an increase in the amount of cells present in the S-phase in the MCF-7 cell line after 72 h of glutamine deprivation. The MDA-MB-231 cell line resulted in a significant increase in cells occupying the G2/M phase after 24 h of glutamine deprivation. Glutamine deprivation in the BT-20 cell line resulted in a significant increase in cells occupying G1 phase after 72 h of glutamine deprivation. The MCF-7 cell line demonstrated the least amount of viable cells when analysing apoptosis induction, when compared to the MDA-MB-231-, MCF-10A- and BT-20 cell lines after glutamine deprivation suggesting that the MCF-7 cell line is the most affected cell line. Analysis of antioxidant mechanism via superoxide dismutase (SOD) inhibition illustrated increased SOD activity in the MCF-7 cell line (9.1%) after 72 h of glutamine deprivation. Evaluation of catalase protein concentration indicated that the MCF-7 catalase expression increased to 1.28 fold after 24 h of glutamine deprivation when compared to cell propagated in complete growth medium. DNA damage was demonstrated by visualising the presence of fluorescent 8-hydroxydeoxyguanosine and showed that the MCF-7 cell line presented with significant 8-hydroxydeoxyguanosine staining. Survival signaling was also evaluated through visualising extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K) signaling which demonstrated increased ERK activation in the non-tumourigenic MCF-10A cell line and decreased PI3K activation. This study provides evidence that there are differential- and time-dependent responses in breast tumourigenic cells versus non-tumourigenic cells, to glutamine deprivation thus unraveling the crosstalk between glutamine deprivation, oxidative stress and cell death and different cell types will enable us to better understand the basics of tumour cell metabolism and thus develop therapeutics that provide promising pre-sensitization potential for chemotherapeutic agents. / Dissertation (MSc)--University of Pretoria, 2020. / Physiology / MSc / Unrestricted

The aim of this work is a literature review on the topic of the mitochondrial genome and DNA barcoding, building a dataset of mitochondrial sequences from GenBank database and creatione of a software function for extraction of individual genes that are present in the mitochondrial genome. This function was developed in Matlab. DNA barcoding is a method that uses short DNA sequence of mitochondrial genome for identification of species. There is no comprehensive work examining the appropriateness of different mitochondrial genes. This aim investigates the potential of other mitochondrial genes and evaluate their effectiveness for DNA barcoding and calculation of intra-and interspecific variability.

Le peptide oncolytique LTX-315 a été développé comme un peptide cationique amphipathique qui tue les cellules cancéreuses et qui se révèle stimulant pour la réponse anti-cancer immune quand il est localement injecté dans des tumeurs présentent chez des souris immunocompétentes. La microscopie électronique par transmission révélées que LTX-315 a échoué à induire la condensation nucléaire apoptotique mais induit plutôt un phénotype nécrotique. Par conséquent, LTX-315 a échoué à stimuler l'activation de caspase-3, et l'inhibition des caspases par le biais de Z-VAD-fmk n'a pas été capable de réduire la mort cellulaire par LTX-315. En outre, deux inhibiteurs importants de la nécroptose, nommés necrostatin-1 et cycospotin-A, ont échoué à réduire la mort cellulaire par LTX-315. En conclusion, il semble que LTX-315 déclenche une nécrose non-régulée, qui peut contribuer à ses effets pro-inflammatoires et pro-immunitaires. Le fractionnement subcellulaire des cellules traitées par LTX-315, suivie par une quantification spectrométrique massive, a révélé que cet agent était enrichi en mitochondries. LTX-315 a causé un arrêt immédiat de la respiration mitochondriale sans aucun effet majeur de découplage. Par conséquent, LTX-315 a interrompu le réseau mitochondrial, a dissipé le potentiel mitochondrial de la membrane interne, et a causé la libération des protéines inter-membranaires mitochondriales dans le cytosol. LTX-315 était relativement inefficace dans la mitophagie stimulante. Les cellules dépourvues de deux pro-apoptotiques protéines à domaines multiples BAX et BAK, étaient moins susceptibles de mourir par LTX-315. De plus, les cellules conçues pour perdre leurs mitochondries étaient relativement résistantes à LTX-315, soulignant l'importance de cet organite pour la cytotoxicité induite par LTX-315. Au total, ces résultats soutiennent la notion que LTX-315 tue les cellules cancéreuses par sa vertue à perméabiliser les membranes mitochondriales. Nous avons observé que LTX-315 induit toutes les charactéristiques d'ICD connues. Cette conclusion a étévalidée par diverses méthodes indépendantes incluant la teinture par immunofluorence, dosage par bioluminescence, immunodosages, RT-PCRs. Quand il a été injecté dans des cancers créés, LTX-315 a causé une nécrose focale transitoirement hémorragique accompagnée d'une libération massive de HMGB1, aussi bien que l'activation de caspase-3 dans une partie des cellules. LTX-315 était au moins aussi efficace que le controle positif, l' anthracycline mitoxantrone en induisant une inflammation locale par infitration de cellules myéloïdes et de lymphocytes T. Collectivement, ces résultats appuient l'idée que LTX-315 peut induire l'ICD, expliquant sa capacité à induire des effets thérapeutiques immuno-dépendants.L'autre Lytix composé LTX-401 est un acide aminé oncolytique dérivé avec des propriétés immunogéniques potentielles. Nous démontrons que LTX-401 détruit sélectivement la strucutre du dispositif Golgi. Le fractionnement subcellulaire suivi par une détection spectométrique massive a révélé que LTX-401 a enrichi sélectivement dans le Golgi mieux que dans la mitochondrie ou dans le cytosol. Lagent Golgi-dissociant Brefeldin A a réduit la mort cellulaire par LTX-401 comme cela a partiellement inhibé la libération mitochondrial induite par LTX-401 de cytochrome C et l'activation de BAX. L'effet cytotoxique de LTX-401 a été atténué par la double suppression de BAX et BAK, comme la déplétion mitophagique forcée de la mitochondrie, déjà réfractaire à l'inhibition de caspase. LTX-401 induit toutes les caractéristiques majeures de la mort cellulaire immunogénique. En outre, les tumeurs traitées par LTX-401 ont manifesté une forte infiltration lymphoïde. Ensemble, ces résultats soutiennent l'idée que LTX-401 peut stimuler la mort immunogétique des cellules à travers un passage dans lequel LTX-401 localisé sur Golgi opère en amont de la perméabilisation de la membrane mitochondriale. / The oncolytic peptide LTX-315 has been developed as an amphipathic cationic peptide that kills cancer cells and turned out to stimulate anticancer immune responses when locally injected into tumors established in immunocompetent mice. We investigated whether LTX-315 induces apoptosis or necrosis. Transmission electron microscopy or morphometric analysis of chromatin-stained tumor cells revealed that LTX-315 failed to induce apoptotic nuclear condensation and rather induced a necrotic phenotype. Accordingly, LTX-315 failed to stimulate the activation of caspase-3. Moreover, inhibition of caspases by Z-VAD-fmk was unable to reduce cell killing by LTX-315. In addition, two prominent inhibitors of necroptosis, necrostatin-1 and cyclosporin A, failed to reduce LTX-315-induced cell death. In conclusion, it appears that LTX-315 triggers unregulated necrosis, which may contribute to its pro-inflammatory and pro-immune effects. Subsequently, we investigated the putative involvement of mitochondria in the cytotoxic action of LTX-315. Subcellular fractionation of LTX-315-treated cells, followed by mass spectrometric quantification, revealed that the agent was enriched in mitochondria. LTX-315 caused an immediate arrest of mitochondrial respiration without any major uncoupling effect. Accordingly, LTX-315 disrupted the mitochondrial network, dissipated the mitochondrial inner transmembrane potential, and caused the release of mitochondrial intermembrane proteins into the cytosol. LTX-315 was relatively inefficient in stimulating mitophagy. Cells lacking the two pro-apoptotic multidomain proteins BAX and BAK, were less susceptible to LTX-315-mediated killing. Moreover, cells engineered to lose their mitochondria were relatively resistant against LTX-315, underscoring the importance of this organelle for LTX-315-mediated cytotoxicity. Altogether, these results support the notion that LTX-315 kills cancer cells by virtue of its capacity to permeabilize mitochondrial membranes. Following, we investigated whether LTX-315 may elicit the hallmarks of immunogenic cell death (ICD). Overally, we observed that LTX-315 induces all known ICD characteristics. This conclusion was validated by several independent methods including immunofluorescence staining, bioluminescence assays, immunoassays, and RT-PCRs. The injection of LTX-315 into established cancers resulted in transiently hemorrhagic focal necrosis that was accompanied by massive release of HMGB1, as well as caspase-3 activation in a fraction of the cells. LTX-315 was equal or more efficient as the positive control, the anthracycline mitoxantrone (MTX), in inducing local inflammation with infiltration by myeloid cells and T lymphocytes. Collectively, these results support the idea that LTX-315 can induce ICD, explaining its capacity to mediate immune-dependent therapeutic effects. The second Lytix compound investigated, LTX-401, is an oncolytic amino acid derivative with potential immunogenic properties. We demonstrated that LTX-401 selectively destroys the structure of the Golgi apparatus. Subcellular fractionation followed by mass spectrometric detection revealed that LTX-401 was selectively enriched in the Golgi rather than in the mitochondria or in the cytosol. The Golgi-dissociating agent Brefeldin A (BFA) reduced cell killing by LTX-401 as it partially inhibited LTX-401-induced mitochondrial release of cytochrome c and the activation of BAX. The cytotoxic effect of LTX-401 was attenuated by the double knockout of BAX and BAK, as well as the mitophagy-enforced depletion of mitochondria, yet was refractory to caspase inhibition. LTX-401 induced all major hallmarks of immunogenic cell death. Moreover, LTX-401-treated tumors manifested a strong lymphoid infiltration. Altogether, these results support the contention that LTX-401 can stimulate immunogenic cell death through a pathway in which Golgi-localized LTX-401 operates upstream of mitochondrial membrane permeabilization.